So close location can be so far to consider if you don't think out of context Cryoablation Persistent Left SVC as an AF trigger P.S. No worries, away from phrenic and coronary #Epeeps

In 1983 Gerard Guiraudon described surgical disarticulation of the RV free wall to treat VT in ARVC. We recently found this to be feasible also with endocardial PFA. More to come #HRS2025 heartrhythmjournal.com/article/S1547-… Alan Kiang Mandeep Bhargava Cleveland Clinic Heart, Vascular & Thoracic

Pulsed-Field Ablation for Non-Pulmonary Vein Foci of Immediate Recurrence of Atrial Fibrillation Originating from the Left Arial Inferior Wall Directly Adjacent to the Esophagus heartrhythmcasereports.com/article/S2214-…

congrats!! Low-voltage-area ablation for persistent atrial fibrillation: a randomized controlled trial Masuda et al. Nature Med. nature.com/articles/s4159…

Mitral annular disjunction is associated with a increased long-term risk of ventricular arrhythmias after mitral valve surgery doi.org/10.1093/eurhea… #VHD #mitralvalve #cardiacsurgery #arrhythmias #cardiotwitter, European Society of Cardiology Journals, European Society of Cardiology

Bjork Fontan modification in 47 yrs old patient with DILV, LTGA. Nice anterior figure of 8 circuit around the Fontan baffle.

Do you always rely on sinus rhythm voltage during atrial mapping? 👇 Change in atrial voltage maps during Cs pacing compared to sinus rhythm in a re-do procedure after PVI. Decremental pacing clearly elucidates functional substrate. pubmed.ncbi.nlm.nih.gov/40391692/ #EPeeps Pacing and Clinical Electrophysiology

Pulmonary vein isolation and low-voltage area ablation in sinus rhythm for persistent atrial fibrillation: The SCAR-AF randomized trial heartrhythmjournal.com/article/S1547-…

A case of Dressler’s Syndrome after pulsed field ablation for atrial fibrillation heartrhythmcasereports.com/article/S2214-…

⚠️ MRI-based AI model for the identification of underlying #Afib after ischemic stroke 🔬 brain ischemic lesion pattern on MR images & underlying AF ✅ AUC of 0.94 (95% CI, 0.90–0.98) for AF detection 🖇️ tinyurl.com/23hcdxhn #ESCStroke #AI #whyCMR The Lancet

Our Ethanol Ablation for VT series! Non-ischemic CMP No endo scar, septal reentry w/ focal endo-epi activation 💡 Intramural circuit suspected ⛔️ Long endo RF → transient VT stop 🎯 Best precocity at AIV septal branch os endo neighbor Ethanol injection VT termination #Epeeps

DIGIT-HF trial has started a snowball effect in heart failure research! Are we in front of the fifth pillar in HFrEF? 🤔 .. Watch my interview with John Mandrola John Mandrola, MD from Louisville, Kentucky, USA and see his 5 learnt lessons from this trial. #ESCCongress European Society of Cardiology

Safety and Effectiveness of a Novel Balloon-in-Basket Pulsed Field Ablation Catheter for the Treatment of Paroxysmal and Persistent AF: VOLT-AF IDE Trial Acute Results #OpenAccess Monica Lo MD FHRS FACC Arkansas Heart Hospital heartrhythmjournal.com/article/S1547-…

Hitting A New PR: Extravascular ICD Implant in a Professional Powerlifter Francis Phan, MD heartrhythmcasereports.com/article/S2214-…

Repatha (evolocumab), a PCSK9 blocker that lowers LDL cholesterol, reduced major adverse cardiovascular events in a large trial of participants with diabetes or atherosclerosis (no prior heart attack or stroke) NEJM #AHA25 nejm.org/doi/full/10.10…

Presented at #AHA25: In patients with atrial fibrillation and a drug-eluting stent placed at least 1 year earlier, monotherapy with a non–vitamin K antagonist oral anticoagulant was noninferior to combination therapy with clopidogrel for net adverse clinical events. Full ADAPT

OPTIMA-AF trial: In AF patients undergoing PCI with EES, 1-month therapy with DOAC + P2Y12 inhibitor was non-inferior for preventing ischemia and superior for reducing bleeding compared to 12-month therapy. #AHA25 View the slides here: clinicaltrialresults.org/wp-content/upl…

CLOSURE-AF results presented at #AHA25

Presented at #AHA25: In patients with atrial fibrillation after successful ablation, rivaroxaban therapy did not lead to a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than aspirin therapy. Full OCEAN trial results:

OCEAN trial: For AF patients with ≥1 risk factor post-catheter ablation, low-dose rivaroxaban showed similar rates of stroke/systemic embolism and major bleeding at 3 years compared to aspirin. #AHA25 View the slides here: clinicaltrialresults.org/wp-content/upl…